A novel method that enables prostate cancer testing that is noninvasive and more accurate than conventional methods is disclosed. The present inventors intensively analyzed urine samples from prostate cancer patients, and non-cancer subjects, who are free of prostate cancer, and, as a result, newly...
Current and investigational biomarkers, including blood- and urine-based assays, improve diagnostic accuracy by supplementing prostate-specific antigen testing. Each biomarker offers unique advantages in detecting, diagnosing, and monitoring prostate cancer, often integrated into risk assessment tools for bette...
Our initial results suggest that home based PSA testing is feasible and may have clinical utility in management of men treated for prostate cancer.Frederick S.LeachMoon S.KohYung W.ChanSamantha BarkRobert RayRonald A.Morton & Alan T.Remaley...
We have constructed and tested a home-based prostate cancer surveillance device for use by patients to detect PSA from blood obtained by finger stick. Our initial results suggest that home based PSA testing is feasible and may have clinical utility in management of men treated for prostate cancer...
HRRm are estimated to be present in up to 28% of patients (pts) with advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC). Testing for HRRm may inform treatment choice in pts with mCRPC. The aim of the study was to assess HRRm testing rate and describe...
To assess the biomarker's abil- ity to distinguish between pancreatic cancer (PC) and acute pancreatitis (AP), a secondary study included 18 cerulein-induced AP cases (3 groups at 24, 48, 72 hours, n=6 for each group) along with 6 saline-injected controls. Testing was carried out at ...
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer. PLoS ONE. 2017;12(8): e0181557. https://doi.org/10.1371/journal.pone.0181557. Article CAS PubMed PubMed Central Google Scholar Zhang X, Huang Q, Yang Z, et...
Cancer exerts a multitude of effects on metabolism, including the reprogramming of cellular metabolic pathways and alterations in metabolites that facilitate inappropriate proliferation of cancer cells and adaptation to the tumor microenvironment. There
Patients & Caregivers: Learn about precision oncology and biomarker testing. Cancer patient, caregiver, and physician perspectives regarding the importance of biomarker testing.
Prostate tissues from 38 patients with cancer and 33 controls with a 10-year prostate cancer-free followup were labeled for pan-cadherin by immunohistochemical testing. Immunoreactivity was quantified using a Pathology Workstation (Autocyte Inc., Elon College, North Carolina). Visually benign glands ...